6IC6
Human cathepsin-C in complex with cyclopropyl peptidyl nitrile inhibitor 1
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | MAX II BEAMLINE I911-2 |
Synchrotron site | MAX II |
Beamline | I911-2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2009-12-10 |
Detector | MARMOSAIC 225 mm CCD |
Wavelength(s) | 1.03796 |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 86.690, 87.770, 115.030 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 28.026 - 1.898 |
Rwork | 0.147 |
R-free | 0.18580 |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | in-house structure |
RMSD bond length | 0.013 |
RMSD bond angle | 1.843 |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | REFMAC |
Refinement software | REFMAC (5.8.0238 2018/15/10) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 28.026 | 1.950 |
High resolution limit [Å] | 1.898 | 1.898 |
Rmerge | 0.050 | 0.394 |
Number of reflections | 34042 | |
<I/σ(I)> | 18.4 | 3.4 |
Completeness [%] | 97.2 | 96 |
Redundancy | 3.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 5 | 291 | 20.0 % (w/v) PEG 6000 0.1 M sodium citrate pH 5.0 |